|
CCNDBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.691750E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.181900E-02 |
| Normal-vs-Stage2 |
5.037000E-01 |
| Normal-vs-Stage3 |
9.616600E-01 |
| Normal-vs-Stage4 |
2.540400E-01 |
| Stage1-vs-Stage2 |
5.137500E-02 |
| Stage1-vs-Stage3 |
7.292000E-02 |
| Stage1-vs-Stage4 |
8.887600E-01 |
| Stage2-vs-Stage3 |
5.310200E-01 |
| Stage2-vs-Stage4 |
1.499640E-01 |
| Stage3-vs-Stage4 |
2.531000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.683800E-01 |
| Normal-vs-AfricanAmerican |
2.180200E-02 |
| Normal-vs-Asian |
1.853840E-01 |
| Caucasian-vs-AfricanAmerican |
1.059420E-01 |
| Caucasian-vs-Asian |
4.808800E-01 |
| AfricanAmerican-vs-Asian |
3.361800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.688000E-01 |
| Normal-vs-Female |
1.677760E-01 |
| Male-vs-Female |
8.278600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.831860E-02 |
| Normal-vs-Age(41-60Yrs) |
4.355800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.289800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.494200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.342300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.481700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.919000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.441800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.465400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.490000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.937600E-01 |
| Classical-VS-Follicular |
5.447800E-02 |
| Classical-VS-Other |
7.356400E-01 |
| Classical-VS-Normal |
2.846500E-02 |
| Tall-VS-Follicular |
3.401600E-01 |
| Tall-VS-Other |
9.493000E-01 |
| Tall-VS-Normal |
4.668800E-01 |
| Follicular-VS-Other |
7.250200E-01 |
| Follicular-VS-Normal |
6.630400E-01 |
| Other-VS-Normal |
8.246400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.490800E-01 |
| Normal-vs-N1 |
9.269200E-01 |
| N0-vs-N1 |
8.902800E-01 |
|
|
